CEVAC IBIRD LYOPHILISATE FOR SUSPENSION FOR CHICKENS
CEVAC IBIRD LYOPHILISATE FOR SUSPENSION FOR CHICKENS
Authorised
- Avian infectious bronchitis virus, type 793/B, strain 1/96, Live
Product identification
Medicine name:
CEVAC IBIRD LYOPHILISATE FOR SUSPENSION FOR CHICKENS
Cevac IBird liofilizāts suspensijas pagatavošanai vistām
Active substance:
- Avian infectious bronchitis virus, type 793/B, strain 1/96, Live
Target species:
-
Chicken (broiler)
-
Chicken (layer hen)
-
Chicken (for reproduction)
Route of administration:
-
Oculonasal use
-
Oral use
Product details
Active substance and strength:
-
Avian infectious bronchitis virus, type 793/B, strain 1/96, Live2.80log 10 50% embryo infective dose1.00Dose
Pharmaceutical form:
-
Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
-
Oculonasal use
-
Chicken (broiler)
-
All relevant tissues0day
-
-
Chicken (layer hen)
-
All relevant tissues0day
-
-
Chicken (for reproduction)
-
All relevant tissues0day
-
-
-
Oral use
-
Chicken (layer hen)
-
All relevant tissues0day
-
-
Chicken (for reproduction)
-
All relevant tissues0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Latvia
Package description:
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
- Available only in Latvian
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Ceva-Phylaxia Zrt.
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva-Phylaxia Veterinary Biologicals Co. Ltd
Responsible authority:
- Food And Veterinary Service
Authorisation number:
- V/DCP/13/0031
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0245/001
Concerned member states:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
This document does not exist in this language (English). You can find it
in another language below.
Latvian (PDF)
Published on: 15/07/2024
How useful was this page?: